Recovery help after jail or prison for opioid risks
This study helps adults who recently left jail, prison, or similar facilities and have risks related to opioid use or HIV. It aims to connect them with treatment and care support starting from the emergency department.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be visiting the Johns Hopkins Hospital Emergency Department.
- You must have left a correctional facility like jail, prison, or a halfway house within the last 180 days.
- You must have opioid use issues or be at risk for HIV.
- You must be able to speak and understand English.
- You must have a reliable phone number for follow-up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a mobile app designed to help women who have recently been in jail or prison reduce their risk of HIV and get support for opioid use. The app may help you stay healthy and connect to prevention and treatment services.
This trial tests an overdose prevention approach for people who have used opioids recently. It aims to help reduce the risk of overdose by offering a structured prevention intervention.
This study tests a better way to start long-acting HIV prevention (PrEP) and buprenorphine for opioid use disorder while people are in jail, to see if it helps them stay healthy after release. If you are soon leaving jail and have opioid use disorder, you may be able to join.
This study looks at ways to improve HIV prevention and treatment for people on probation who have injected opioids. Researchers want to learn from your experiences to help create better services.
This study helps people with HIV or high risk of HIV who have had substance use problems and are in jail or recently released. It tests a program called SUCCESS-E to support health and reduce drug use.
This study tests how to better support HIV prevention for people who inject drugs and are newly starting PrEP (medicine to prevent HIV). It focuses on people taking medication for opioid use disorder and who have mild thinking and memory problems, to help them stay safe and adhere to prevention.
Hear when a new Harm Reduction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.